Pruritic Manifestation of Peripheral T Cell Lymphoma Effectively Managed with Mirtazapine: A Case Report

Hannah Bromberg Hannah Bromberg, DO, Palliative Care Department, H. Lee Moffitt Cancer Center, Tampa, Florida, USA; Young Chang, MD, Palliative Care Department, H. Lee Moffitt Cancer Center, Tampa, Florida, USA; David Craig, PharmD, Palliative Care Department, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.Correspondence[email protected]

Young Chang Hannah Bromberg, DO, Palliative Care Department, H. Lee Moffitt Cancer Center, Tampa, Florida, USA; Young Chang, MD, Palliative Care Department, H. Lee Moffitt Cancer Center, Tampa, Florida, USA; David Craig, PharmD, Palliative Care Department, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.

David Craig Hannah Bromberg, DO, Palliative Care Department, H. Lee Moffitt Cancer Center, Tampa, Florida, USA; Young Chang, MD, Palliative Care Department, H. Lee Moffitt Cancer Center, Tampa, Florida, USA; David Craig, PharmD, Palliative Care Department, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.

References

Stander S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, Bergasa NV, Gieler U, Misery L, Wallengren J, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol. 2007;87:291–4. doi:10.2340/00015555-0305.
PubMed Web of Science ®Google Scholar
Lee JJ, Girouard SD, Carlberg VM, Mostaghimi A. Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse. BMJ Support Palliat Care. 2016;6(1):119–21. doi:10.1136/bmjspcare-2014-000790.
PubMed Web of Science ®Google Scholar
Demierre MF, Gan S, Jones J, Miller DR. Significant impact of cutaneous T cell lymphoma on patients’ quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey. Cancer. 2006;107(10):2504–11. doi:10.1002/cncr.22252.
PubMed Web of Science ®Google Scholar
Lewis DJ, Huang S, Duvic M. Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma. J Eur Acad Dermatol Venereol. 2018;32(10):1652–6. doi:10.1111/jdv.15075.
PubMed Web of Science ®Google Scholar
Khanna R, Boozalis E, Belzberg M, Zampella J, Kwatra S. Mirtazapine for the treatment of chronic pruritus. Medicines. 2019;6(3):73. doi:10.3390/medicines6030073.
Google Scholar
Davis MP, Frandsen JL, Walsh D, Andresen S, Taylor S. Mirtazapine for pruritis. J Pain Symptom Manage. 2003;25(3):288–91. doi:10.1016/S0885-3924(02)00645-0.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Pruritic Manifestation of Peripheral T Cell Lymphoma Effectively Managed with Mirtazapine: A Case Report

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Pruritic Manifestation of Peripheral T Cell Lymphoma Effectively Managed with Mirtazapine: A Case Report

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date